Matt Hewitt
Stock Analyst at Craig-Hallum
(3.53)
Main Sectors:
19 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SLP Simulations Plus | Maintains: Buy | 45 36 | 14.89 | 141.77% | 8 | Jun 13, 2025 | |
CSBR Champions Oncology | Maintains: Strong Buy | 8 12 | 6.3 | 90.48% | 4 | Mar 12, 2025 | |
BLFS BioLife Solns | Maintains: Strong Buy | 30 32 | 24.7 | 29.55% | 4 | Nov 13, 2024 | |
OMCL Omnicell | Maintains: Strong Buy | 45 64 | 30.72 | 108.33% | 5 | Oct 31, 2024 | |
LGND Ligand Pharmaceutica... | Maintains: Strong Buy | 135 140 | 169.72 | -17.51% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 1.38 | 624.64% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 30 | 19.3 | 55.44% | 3 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 23 | n/a | n/a | 1 | Jan 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 16 | n/a | n/a | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | 1.53 | 357.52% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 207 200 | 125.61 | 59.22% | 3 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.61 | 521.12% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 5 2 | n/a | n/a | 2 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 3 2 | n/a | n/a | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 67 30 | 8.14 | 268.55% | 5 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 400 | 1.17 | 34088.03% | 1 | Jan 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 21 30 | n/a | n/a | 3 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Jul 24, 2017 |